Make sure to sign up for an account today for exclusive coupons and free shipping on orders over $75!
Maximum quantity allowed is 999
CAS RN: 138402-11-6 | Product Number: I0859
Irbesartan
Purity: >98.0%(T)(HPLC)
Size | Unit Price | Philadelphia, PA | Portland, OR | Japan* | Quantity |
---|---|---|---|---|---|
1G |
$74.00
|
1 | 1 | ≥40 |
|
5G |
$214.00
|
1 | 1 | ≥40 |
|
* Items in stock locally ship in 1-2 business days. Items from Japan stock are able to ship from a US warehouse within 2 weeks. Please contact TCI for lead times on items not in stock. Excludes regulated items and items that ship on ice.
* To send your quote request for bulk quantities, please click on the "Request Quote" button. Please note that we cannot offer bulk quantities for some products.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
Product Number | I0859 |
Purity / Analysis Method | >98.0%(T)(HPLC) |
Molecular Formula / Molecular Weight | C__2__5H__2__8N__6O = 428.54 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
CAS RN | 138402-11-6 |
Reaxys Registry Number | 6620400 |
PubChem Substance ID | 172088930 |
Merck Index (14) | 5083 |
MDL Number | MFCD00864464 |
Appearance | White to Almost white powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Purity(Neutralization titration) | min. 98.0 % |
Melting point | 184.0 to 188.0 °C |
Melting Point | 188 °C |
Solubility in water | Insoluble |
Hazard Statements | H413 : May cause long lasting harmful effects to aquatic life. |
Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P273 : Avoid release to the environment. |
RTECS# | HM2950270 |
HS Number | 2933.29.2000 |
References
- Angiotensin Type 1 Receptor Blockers Induce Peroxisome Proliferator-Activated Receptor-gamma Activity
- Selective angiotensin II receptor antagonism reduces insulin resistance in obese Zucker rats
- Pharmacological characterization of SR 47436, a new nonpeptide AT1 subtype angiotensin II receptor antagonist
- C. Cazaubon, J. Gougat, F. Bousquet, P. Guiraudou, R. Gayraud, C. Lacour, A. Roccon, G. Galindo, G. Barthelemy, B. Gautret, J. Pharmacol. Exp. Ther. 1993, 265, 826.
- Role of cytochrome P-4502C9 in irbesartan oxidation by human liver microsomes
- M. Bourrié, V. Meunier, Y. Berger, G. Fabre, Drug Metab. Dispos. 1999, 27, 288.
References
- Irbesartan: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in the management of hypertension
- The new angiotensin II receptor antagonist, irbesartan: pharmacokinetic and pharmacodynamics considerations (a review)
Articles/Brochures
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.